ClinicalTrials.govpublic full text
Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors
metastatic bladder urothelial carcinoma, metastatic malignant solid neoplasm, stage iv bladder cancer ajcc v8, mtap deletion, kmt2d (gene)/mll4 (protein) or kdm6a (gene)/utx (protein) or mtap loss of function mutations, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1047395
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.